Physician profile
David E Dahl
NPI 1841516937
$5,062.43
in general payments reported to CMS, 2019-2025
23 companies · $1,421 in 2025
The $1,421 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,843 · 2020: $618 · 2021: $15.33 · 2023: $131 · 2024: $1,034 · 2025: $1,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,515 · Travel and Lodging: $70.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,515.46 |
| Travel and Lodging | $70.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,575.82 | 2024-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $1,444.63 | 2019-2020 | |
| Boston Scientific Corporation | $700.14 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $424.40 | 2019-2024 | Senza |
| Abbott Laboratories | $120.66 | 2025 | Eterna |
| Scilex Pharmaceuticals INC. | $104.73 | 2019-2025 | |
| Stimwave Technologies Incorporated | $100.00 | 2019 | |
| Tersera Therapeutics LLC | $90.29 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.10 | 2024-2025 | Relistor |
| Pacira Therapeutics, INC. | $50.89 | 2019 | |
| Biodelivery Sciences International, INC. | $45.10 | 2019-2020 | |
| Globus Medical, INC. | $45.07 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $43.61 | 2020-2025 | Belbuca |
| Vertex Pharmaceuticals Incorporated | $41.24 | 2024-2025 | |
| Zyla Life Sciences, INC. | $37.04 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $33.35 | 2019-2025 | |
| Grt US Holding, INC. | $32.30 | 2020 | |
| Spr Therapeutics, INC | $25.22 | 2025 | Sprint Pns System |
| Biotronik Nro, INC. | $23.48 | 2025 | Prospera |
| Saluda Medical Americas, INC. | $15.95 | 2025 | Evoke |
| Alexion Pharmaceuticals, INC. | $14.26 | 2019 | |
| Assertio Therapeutics, INC. | $13.49 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.